Dr. Peter Scott Levin, MD

Dr. Levin practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Levin's NPI, 1568570364, was assigned on August 29, 2006. Dr. Levin graduated from The Johns Hopkins University School of Medicine in 1983. Dr. Levin holds California license G52783.

Dr. Levin's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Levin's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Levin to 1 more hospital and 1 medical group, each named with a free account. Dr. Levin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levin practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Levin's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Levin is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Levin's licenses on file in 2 states: California and North Carolina.

Dmand AI lists dry eye and eyelid inflammation among the conditions Dr. Levin treats.

CMS data shows 166 Medicare services from Dr. Levin across 4 procedure codes in 2024, for 103 Medicare patients. Medicare paid $13,225 for them. Every service was in an office.

CMS counts 103 Medicare patients who saw Dr. Levin in 2024. The largest group is 65 to 74, with 44 patients. 59% of them have high cholesterol, and 58% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Levin's median patient age at 59, with 61% women.

In 2024, Dr. Levin wrote 21 Medicare Part D claims for 15 patients. 76% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $169 in total drug cost. In 2019, CMS named 45 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Levin for performance year 2024, reported as part of a group. Dr. Levin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Levin. The most frequent topics are Orbital Diseases, Graves Disease and Orbit. Dr. Levin has published most often in Am J Ophthalmol. Dr. Levin's most frequent co-authors are Joel Lee Cohen, MD, Sarah S. Donaldson, MD and Hayes Bordman Gladstone, MD.

CMS Open Payments shows 8 general payments to Dr. Levin from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Galderma Laboratories, L.P. paid the most, $345.

Dmand AI lists 3 awards for Dr. Levin, most recently Regional Top Doctor in 2014.

Dr. Levin graduated from The Johns Hopkins University School of Medicine in 1983. Dr. Levin is a member of AAO and ACS.

Dr. Levin is in network with 4 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.